ESC Premium Access

Survival after septal myectomy in male and female patients with hypertrophic obstructive cardiomyopathy

Congress Presentation

About the speaker

Mr Roy Huurman

Erasmus University Medical Center, Rotterdam (Netherlands (The))
0 follower

5 more presentations in this session

Comparison of long-term clinical course and outcome of MYBPC3 - versus MYH7 - related hypertrophic cardiomyopathy.

Speaker: Doctor C. Fumagalli (Florence, IT)


In a prospective randomized study in familial hypertrophic cardiomyopathy, metoprolol maintains exercise-performance, with lower myocardial oxygen-cost, and prevents deterioration in exercise-ability

Speaker: Professor I. Ostman-Smith (Goteborg, SE)


Myocardial transit time (MTT) - a novel and easy-to-perform CMR parameter to assess microvascular disease.

Speaker: Mr G. Chatzantonis (Munster, DE)


FLNC pathogenic variants in patients with various cardiomyopathies:prevalence and genotype-phenotype correlations

Speaker: Doctor F. Ader (Paris, FR)


Characteristics and clinical significance of right ventricular involvement in patients with hypertrophic cardiomyopathy

Speaker: Doctor K. Choi (Seoul, KR)


Access the full session

Clinical, imaging and genetic advances in hypertrophic cardiomyopathy

Speakers: Mr R. Huurman, Doctor C. Fumagalli, Professor I. Ostman-Smith, Mr G. Chatzantonis, Doctor F. Ader...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb